rs397516677
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001399.5(EDA):c.871G>A(p.Gly291Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,098,115 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G291W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001399.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDA | NM_001399.5 | c.871G>A | p.Gly291Arg | missense_variant | 7/8 | ENST00000374552.9 | NP_001390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDA | ENST00000374552.9 | c.871G>A | p.Gly291Arg | missense_variant | 7/8 | 1 | NM_001399.5 | ENSP00000363680 | P4 | |
EDA | ENST00000374553.6 | c.871G>A | p.Gly291Arg | missense_variant | 7/8 | 1 | ENSP00000363681 | A1 | ||
EDA | ENST00000524573.5 | c.862G>A | p.Gly288Arg | missense_variant | 7/8 | 1 | ENSP00000432585 | A1 | ||
EDA | ENST00000616899.1 | c.475G>A | p.Gly159Arg | missense_variant | 6/7 | 5 | ENSP00000481963 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098115Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 363471
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hypohidrotic X-linked ectodermal dysplasia Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 24, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 291 of the EDA protein (p.Gly291Arg). This missense change has been observed in individual(s) with hypohidrotic/anhidrotic ectodermal dysplasia (PMID: 9736768, 20979233, 21357618, 22032522, 23553579). This variant is also known as c.1113G>A. ClinVar contains an entry for this variant (Variation ID: 44211). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EDA protein function. - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 17, 2011 | The Gly291Arg variant in EDA has been reported in at least 11 individuals with X -linked hypohidrotic ectodermal dysplasia. It was reported as de novo in two of these individuals and was absent from over 300 control chromosomes (Bayes 1998, Cluzeau 2011, Schneider 2001, Schneider 2011, Sekiguchi 2005, LMM unpublished d ata). In summary, this variant meets our criteria to be classified as pathogeni c. - |
Pathogenic, criteria provided, single submitter | research | Medical Molecular Genetics Department, National Research Center | Feb 13, 2021 | - - |
Anhidrotic ectodermal dysplasia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 18, 2023 | Variant summary: EDA c.871G>A (p.Gly291Arg) results in a non-conservative amino acid change located in a critical position within the Tumour necrosis factor domain (IPR006052) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183325 control chromosomes. c.871G>A has been reported in the literature in multiple individuals affected with Hypohidrotic Ectodermal Dysplasia (example, Bayes_1998, Sekiguchi_2005, Zeng_2015, Kang_2022, Park_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 15663448, 9736768, 26411740, 36071541, 31129666, 11279189, 18231121). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 05, 2021 | Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); Identified in multiple patients with X-linked hypohidrotic ectodermal dysplasia referred for genetic testing at GeneDx and in published literature (Schneider et al., 2001; Bayes et al., 1998; Cluzeau et al., 2011); This variant is associated with the following publications: (PMID: 9736768, 22032522, 23553579, 18231121, 21357618, 24033266, 20979233, 19278982, 11279189, 31129666) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at